|
The International Academy of Compounding Pharmacists (IACP) has submitted formal comments today to the Illinois Department of Financial and Professional Regulation on Proposed Amendments to Regulations Implementing Illinois Pharmacy Practice Act.
Today's submission reflects IACP's continuing effort to respond to each and every state action impacting pharmacy compounding. IACP will continue these efforts in 2018 and will work closely with State Pharmacist Associations and State Boards of Pharmacy to support all state action preserving patient access to compounded medications. The
IACP Legislative Committee
chaired by
IACP Board Member Anthony Grzib, RPh
is continuing to look for additional ways IACP can engage in preserving patient access to compounded medications.
Please click here
to read IACP's comments.
IACP urges our members and corporate members also to
submit your own comments to the Illinois Department of Financial and Professional Regulation
. You are welcome and urged to use our comments in submitting your own. Our understanding is that these comments are due, TODAY.
How to Submit Comments:
Comments can be submitted in writing to:
Craig Cellini
Illinois Department of Financial and Professional Regulation
320 West Washington, 3rd Floor
Springfield, Illinois 62786
Because comments are due today, we recommend you also email your comments to Craig Cellini at
[email protected].
IACP Comments Excerpt:
IACP would like to thank the Illinois Department of Financial and Professional Regulation
("IDFPR") for this opportunity to present thoughts on the proposed amendments to Section 1130.640 of the Illinois regulations implementing the Pharmacy Practice Act (the "Proposed Rules"). IACP supports the IDFRP's mission to ensure that patients throughout the State of Illinois receive safe, effective and quality compounded medications. IACP understands and supports the need to protect public health. When developing and implementing regulations, it is essential to preserve patient access to vital compounded medications, the prescriber-patient-pharmacist triad, and the right of a patient to choose their pharmacist. Prescribers must have the right to prescribe medications that best fit the needs of their patients.
IACP has reviewed the Proposed Rules and would like to recognize the IDFPR for incorporating much of the stakeholder input submitted during prior comment and review periods. IACP has heard from pharmacists as well as prescribers who will be impacted by the Proposed Rules that specific provisions still exist within the Proposed Rules that need further clarification or will cause unnecessary constraints in patients being able to access needed compounded preparations.
First, IACP had the opportunity to review the recommendations being submitted by the Illinois Pharmacists Association ("IPhA") and would like to express support for the IPhA's proposed modifications to Sections 1130.640(c),(d),(e), and (f) of the Illinois regulations. IPhA's proposed changes are necessary to ensure that these portions of Section 1130.640 incorporate consistent practice requirements that align with United States Pharmacopeia ("USP") General Chapters 795 and 797 standards currently governing compounding pharmacies. The IPhA's recommendations in these areas will safe-guard patient safety and place the Proposed Rules in line with best practices while also preserving patient access to compounded medications. Read the entire letter
here.
Thank you for being an IACP Member and for standing up for your patients!
|
